Yao Qiang, Zhang Weiming, Qian Jiaqi
Shanghai Center for Hemodialysis Quality Control, Shanghai Municipal Bureau of Health, Shanghai, People's Republic of China.
Ethn Dis. 2009 Spring;19(1 Suppl 1):S1-23-6.
As economic development continues in China, it is important to evaluate recent changes in dialysis status. However, China lacks a national dialysis registry. This elevates the need to use local registry systems like the Shanghai Dialysis Registry to gain an overview of dialysis status in developed cities in China.
Data were collected from the Shanghai Dialysis Registry from the beginning of 2000 to the end of 2005. All dialysis centers (n = 58) in Shanghai are included in the registry system.
Point prevalence of dialysis on December 31, 2005, was 5496, compared with 4842 in 2000. In 2005, 3746 patients began dialysis, yielding a treatment rate of 275.4 patients per million population. The percentage of peritoneal dialysis patients was 18% in 2005, compared with 14% in 2000. The main cause for end-stage renal disease was chronic glomerulonephritis. However, the incidence of diabetic nephropathy increased from 9.9% in 2000 to 17.2% in 2005 and counts as the second major cause of end-stage renal disease. The death rate of patients on dialysis decreased from 9.2% in 2000 to 7.5% in 2005. Cerebrovascular disease was still the leading cause of death and decreased significantly from 2.4% in 2000 to 1.5% in 2005. Dialysis adequacy, hepatitis infection control, and anemia treatment improved.
The Shanghai dialysis population grew continuously during the period covered by this study (2000 to 2005). Clinical outcomes improved because of prompt treatment for co-morbidities.
随着中国经济的持续发展,评估透析状况的近期变化具有重要意义。然而,中国缺乏全国性的透析登记系统。因此,有必要利用上海透析登记系统等地方登记系统来全面了解中国发达城市的透析状况。
收集了上海透析登记系统2000年初至2005年末的数据。上海所有58家透析中心均纳入该登记系统。
2005年12月31日的透析点患病率为5496例,2000年为4842例。2005年,3746例患者开始透析,治疗率为每百万人口275.4例。2005年腹膜透析患者的比例为18%,2000年为14%。终末期肾病的主要原因是慢性肾小球肾炎。然而,糖尿病肾病的发病率从2000年的9.9%升至2005年的17.2%,成为终末期肾病的第二大主要原因。透析患者的死亡率从2000年的9.2%降至2005年的7.5%。脑血管疾病仍是主要死因,且从2000年的2.4%显著降至2005年的1.5%。透析充分性、肝炎感染控制和贫血治疗均有所改善。
在本研究涵盖的时期(2000年至2005年),上海的透析人群持续增长。由于对合并症的及时治疗,临床结局得到改善。